Literature DB >> 18180295

Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.

Karen Taylor1, David J Clarke, Bryan McCullough, Wutharath Chin, Emily Seo, De Yang, Joost Oppenheim, Dusan Uhrin, John R W Govan, Dominic J Campopiano, Derek MacMillan, Perdita Barran, Julia R Dorin.   

Abstract

beta-Defensins are important in mammalian immunity displaying both antimicrobial and chemoattractant activities. Three canonical disulfide intramolecular bonds are believed to be dispensable for antimicrobial activity but essential for chemoattractant ability. However, here we show that HBD3 (human beta-defensin 3) alkylated with iodoactemide and devoid of any disulfide bonds is still a potent chemoattractant. Furthermore, when the canonical six cysteine residues are replaced with alanine, the peptide is no longer active as a chemoattractant. These findings are replicated by the murine ortholog Defb14. We restore the chemoattractant activity of Defb14 and HBD3 by introduction of a single cysteine in the fifth position (Cys V) of the beta-defensin six cysteine motif. In contrast, a peptide with a single cysteine at the first position (Cys I) is inactive. Moreover, a range of overlapping linear fragments of Defb14 do not act as chemoattractants, suggesting that the chemotactic activity of this peptide is not dependent solely on an epitope surrounding Cys V. Full-length peptides either with alkylated cysteine residues or with cysteine residues replaced with alanine are still strongly antimicrobial. Defb14 peptide fragments were also tested for antimicrobial activity, and peptides derived from the N-terminal region display potent antimicrobial activity. Thus, the chemoattractant and antimicrobial activities of beta-defensins can be separated, and both of these functions are independent of intramolecular disulfide bonds. These findings are important for further understanding of the mechanism of action of defensins and for therapeutic design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180295     DOI: 10.1074/jbc.M709238200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

2.  Strain-specific polymorphisms in Paneth cell α-defensins of C57BL/6 mice and evidence of vestigial myeloid α-defensin pseudogenes.

Authors:  Michael T Shanahan; Hiroki Tanabe; André J Ouellette
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Production of bioactive sheep β-defensin-1 in Pichia pastoris.

Authors:  Pengwei Zhao; Guifang Cao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-06-04       Impact factor: 3.346

4.  Peptide fragments of a beta-defensin derivative with potent bactericidal activity.

Authors:  Natalie L Reynolds; Martin De Cecco; Karen Taylor; Chloe Stanton; Fiona Kilanowski; Jason Kalapothakis; Emily Seo; Dusan Uhrin; Dominic Campopiano; John Govan; Derek Macmillan; Perdita Barran; Julia R Dorin
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 5.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

Authors:  Nicole K Brogden; Kim A Brogden
Journal:  Int J Antimicrob Agents       Date:  2011-07-05       Impact factor: 5.283

6.  Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells.

Authors:  Jeffrey P Meisch; Ryan M Vogel; Daniela M Schlatzer; Xiaolin Li; Mark R Chance; Alan D Levine
Journal:  J Leukoc Biol       Date:  2013-06-26       Impact factor: 4.962

7.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

8.  Molecular diversity of the antimicrobial domain of beta-defensin 3 and homologous peptides.

Authors:  Gerardo M Nava; Magdalena Escorcia; M Pilar Castañeda
Journal:  Comp Funct Genomics       Date:  2009-11-02

9.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6.

Authors:  Karen Taylor; Mark Rolfe; Natalie Reynolds; Fiona Kilanowski; Uday Pathania; Dave Clarke; De Yang; Joost Oppenheim; Kay Samuel; Sarah Howie; Perdita Barran; Derek Macmillan; Dominic Campopiano; Julia Dorin
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.